The AIDS Malignancy Program supports pre-clinical and clinical studies for the treatment of cancer in HIV+ and immunocompromised patients. The AMP also supports resources for preclinical and translational/interdisciplinary studies including a tissue repository of well characterized specimens collected from HIV+ and HIV- patients, and infrastructure at institutions that receive significant AIDS funding.

8th International Conference on Malignancies in AIDS and Other Immunodeficiencies: Basic, Epidemiologic and Clinical April 29-30, 2004 National Institutes of Health Campus, Bethesda, Maryland

New Initiative: National Cooperative Drug Discovery Groups for Cancer (RFA-CA-05-001) Application Receipt Deadline: May 19, 2004

2004 AIDS-Oncology Resources Handbook (PDF) Current scope of NCI activities in AIDS malignancies Note: PDF documents can be viewed by anyone with Adobe Acrobat Reader. Download the free Adobe Acrobat Reader

Other Resources

AIDS-associated Malignancies Clinical Trials Consortium NCI-supported clinical trials group

AIDS and Cancer Specimen Resource NCI-supported specimen resource

AIDS International Training and Research Program NIH-supported program

AIDS Malignancies Working Group NCI Advisory Group

Centers for AIDS Research (CFAR) NIH-supported program

HIV and AIDS Malignancy Branch, NCI Clinical research at NCI

Multicenter AIDS Cohort Study (MACS) NIH-supported multicenter, prospective study

Women's Interagency HIV Study (WIHS) NIH-supported multicenter, prospective study